Function of the diabetic retina after panretinal argon laser photocoagulation. Influence of the intensity of the coagulation spots
- PMID: 2017326
- DOI: 10.1159/000310163
Function of the diabetic retina after panretinal argon laser photocoagulation. Influence of the intensity of the coagulation spots
Abstract
To investigate the influence of the intensity of coagulation spots on retinal function and the clinical course after panretinal argon laser photocoagulation in diabetic retinopathy, we conducted a prospective study in 24 eyes of 12 diabetics. One eye was treated with moderate spots (average: 300 mW), the fellow eye was coagulated with intense spots (average: 600 mW). The spot size was identical in both eyes. Subjective parameters (visual acuity, perimetry), as well as objective functions (ERG, EOG) and the clinical course, were studied preoperatively and on a regular base with a follow-up of 12 months. Visual acuity and fundus findings deteriorated less often in eyes coagulated with intense spots. Visual field loss, however, was more prevalent in eyes treated with intense spots. Early treatment complications only occurred with high-energy coagulation. For this reason, high-energy spots should not be used even though they might be indicated theoretically.
Similar articles
-
Panretinal photocoagulation in diabetic retinopathy: argon versus dye laser coagulation.Graefes Arch Clin Exp Ophthalmol. 1993 Jun;231(6):318-22. doi: 10.1007/BF00919027. Graefes Arch Clin Exp Ophthalmol. 1993. PMID: 8339946 Clinical Trial.
-
Function of the diabetic retina after panretinal argon laser coagulation.Graefes Arch Clin Exp Ophthalmol. 1987;225(6):385-90. doi: 10.1007/BF02334163. Graefes Arch Clin Exp Ophthalmol. 1987. PMID: 3678848
-
[Results of laser photocoagulation in patients with diabetic retinopathy developed as a complication of diabetes type 2].Klin Oczna. 2006;108(1-3):66-9. Klin Oczna. 2006. PMID: 16883944 Polish.
-
Visual prognosis after panretinal photocoagulation for proliferative diabetic retinopathy.Acta Ophthalmol Scand. 2006 Feb;84(1):16-20. doi: 10.1111/j.1600-0420.2005.00574.x. Acta Ophthalmol Scand. 2006. PMID: 16445434
-
Electrical responses from diabetic retina.Prog Retin Eye Res. 1998 Jan;17(1):59-76. doi: 10.1016/s1350-9462(97)00005-0. Prog Retin Eye Res. 1998. PMID: 9537795 Review.
Cited by
-
Visual field loss after argon laser panretinal photocoagulation in diabetic retinopathy: full- versus mild-scatter coagulation.Int Ophthalmol. 1998;22(5):313-9. doi: 10.1023/a:1006367029134. Int Ophthalmol. 1998. PMID: 10826550
-
Macular function assessed with mfERG before and after panretinal photocoagulation in patients with proliferative diabetic retinopathy.Doc Ophthalmol. 2004 Sep;109(2):115-21. doi: 10.1007/s10633-004-4862-y. Doc Ophthalmol. 2004. PMID: 15881256
-
Panretinal photocoagulation in diabetic retinopathy: argon versus dye laser coagulation.Graefes Arch Clin Exp Ophthalmol. 1993 Jun;231(6):318-22. doi: 10.1007/BF00919027. Graefes Arch Clin Exp Ophthalmol. 1993. PMID: 8339946 Clinical Trial.
-
Patient preferences in the treatment of diabetic retinopathy.Patient Prefer Adherence. 2011;5:229-37. doi: 10.2147/PPA.S11972. Epub 2011 May 24. Patient Prefer Adherence. 2011. PMID: 21660105 Free PMC article.
-
Field loss after pan retinal photocoagulation with diode and argon lasers.Doc Ophthalmol. 1992;82(4):317-22. doi: 10.1007/BF00161019. Doc Ophthalmol. 1992. PMID: 1306479 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical